This is a limited company view. Sign up for a Free Trial to see everything.

MabVax is a biopharmaceutical companyfocused on the commercialization of proprietary anti-cancer immunotherapies.

B2B
Biotechnology
Cleantech
Healthcare
Medical Diagnostics
Pharmaceuticals
Wind Power

Overview

Location

San Diego

Founded

2006

Employees

17

Stage

Acquired

Total funding

$29M

Last funding

6 months ago

Acquisitions

1

Growth score

-26

Mindshare score

-26

Scoring

Deals

$1.3M Post IPO Equity

Aug 14, 2017

$4.1M Series G

May 22, 2017

$11.6M Post IPO Equity

Apr 9, 2015

$4.6M Series A

May 22, 2014

Employee Growth

Use MabVax Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use MabVax Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Chief Business Officer
Chief Financial Officer
Senior Director of Finance
Clinical Data Manager
Director Clinical Operations
Board Member
Controller
Process Development Associate
Office Manager

Similar Companies

Nuvilex

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R).
Pre-Series A|2 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes